This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molinier-Frenkel, V.
Right arrow Articles by Farace, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molinier-Frenkel, V.
Right arrow Articles by Farace, F.

 Previous Article  |  Next Article 

Journal of Virology, August 2000, p. 7678-7682, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes

Valérie Molinier-Frenkel,1,dagger Hanne Gahery-Segard,2 Majid Mehtali,3 Christophe Le Boulaire,1 Sébastien Ribault,3 Pierre Boulanger,4 Thomas Tursz,1 Jean-Gérard Guillet,2 and Françoise Farace1,*

Départements de Biologie Clinique ou de Médecine, Institut Gustave Roussy, 94805 Villejuif,1 Laboratoire d'Immunologie des Pathologies Infectieuses et Tumorales, INSERM U445, Institut Cochin de Génétique Moléculaire, Université R. Descartes, Hôpital Cochin, 75014 Paris,2 Transgène S.A., 67000 Strasbourg,3 and Laboratoire de Virologie et Pathogénèse Virale, CNRS UMR 5537, Faculté de Médecine RTH Laennec, 69008 Lyon,4 France

Received 30 March 2000/Accepted 17 May 2000

We previously demonstrated that a single injection of 109 PFU of recombinant adenovirus into patients induces strong vector-specific immune responses (H. Gahéry-Ségard, V. Molinier-Frenkel, C. Le Boulaire, P. Saulnier, P. Opolon, R. Lengagne, E. Gautier, A. Le Cesne, L. Zitvogel, A. Venet, C. Schatz, M. Courtney, T. Le Chevalier, T. Tursz, J.-G. Guillet, and F. Farace, J. Clin. Investig. 100:2218-2226, 1997). In the present study we analyzed the mechanism of vector recognition by cytotoxic T lymphocytes (CTL). CD8+ CTL lines were derived from two patients and maintained in long-term cultures. Target cell infections with E1-deleted and E1-plus E2-deleted adenoviruses, as well as transcription-blocking experiments with actinomycin D, revealed that host T-cell recognition did not require viral gene transcription. Target cells treated with brefeldin A were not lysed, indicating that viral input protein-derived peptides are associated with HLA class I molecules. Using recombinant capsid component-loaded targets, we observed that the three major proteins could be recognized. These results raise the question of the use of multideleted adenoviruses for gene therapy in the quest to diminish antivector CTL responses.

* Corresponding author. Mailing address: Département de Biologie Clinique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France. Phone: 33 1 42114478. Fax: 33 1 42115268. E-mail: farace{at}igr.fr.

dagger Present address: Laboratoire d'Immunologie des Pathologies Infectieuses et Tumorales, INSERM U445, Institut Cochin de Génétique Moléculaire, Université R. Descartes, Hôpital Cochin, 75014 Paris, France.

Journal of Virology, August 2000, p. 7678-7682, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Puntel, M., Barrett, R. J., Mondkar, S., Saxena, V., Kroeger, K. M., Muhammad, A. K. M., Liu, C., Bondale, N., Sciascia, S., Xiong, W., Shi, Y., Salem, A., Zadmehr, A., Huynh, P., Palmer, D., Ng, P., Castro, M. G., Lowenstein, P. R. (2009). Herpes Simplex Virus Type 1 Thymidine Kinase Sequence Fused to the lacZ Gene Increases Levels of {beta}-Galactosidase Activity per Genome of High-Capacity but Not First-Generation Adenoviral Vectors In Vitro and In Vivo. J. Virol. 83: 2004-2010 [Abstract] [Full Text]  
  • Pialoux, G., Quercia, R. P., Gahery, H., Daniel, N., Slama, L., Girard, P.-M., Bonnard, P., Rozenbaum, W., Schneider, V., Salmon, D., Guillet, J.-G. (2008). Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study. CVI 15: 562-568 [Abstract] [Full Text]  
  • Carofino, B. C., Lieberman, J. R. (2008). Gene Therapy Applications for Fracture-Healing. JBJS 90: 99-110 [Abstract] [Full Text]  
  • Miyamoto, T., Kaneko, T., Yamashita, M., Tenda, Y., Inami, M., Suzuki, A., Ishii, S., Kimura, M., Hashimoto, K., Shimada, H., Yahata, H., Ochiai, T., Saito, I., DeGregori, J., Nakayama, T. (2005). Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administration. Int Immunol 17: 759-768 [Abstract] [Full Text]  
  • Trapp, S., von Einem, J., Hofmann, H., Kostler, J., Wild, J., Wagner, R., Beer, M., Osterrieder, N. (2005). Potential of Equine Herpesvirus 1 as a Vector for Immunization. J. Virol. 79: 5445-5454 [Abstract] [Full Text]  
  • Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Koudstaal, W., Pau, M. G., Kostense, S., Havenga, M. J. E., Goudsmit, J., Letvin, N. L., Barouch, D. H. (2004). Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors. J. Virol. 78: 2666-2673 [Abstract] [Full Text]  
  • Molinier-Frenkel, V., Prevost-Blondel, A., Hong, S.-S., Lengagne, R., Boudaly, S., Magnusson, M. K., Boulanger, P., Guillet, J.-G. (2003). The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain. J. Biol. Chem. 278: 37175-37182 [Abstract] [Full Text]  
  • Heemskerk, B., Veltrop-Duits, L. A., van Vreeswijk, T., ten Dam, M. M., Heidt, S., Toes, R. E. M., van Tol, M. J. D., Schilham, M. W. (2003). Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy. J. Virol. 77: 6562-6566 [Abstract] [Full Text]  
  • Roth, M. D., Cheng, Q., Harui, A., Basak, S. K., Mitani, K., Low, T. A., Kiertscher, S. M. (2002). Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses. J. Immunol. 169: 4651-4656 [Abstract] [Full Text]  
  • Thomas, C. E., Edwards, P., Wickham, T. J., Castro, M. G., Lowenstein, P. R. (2002). Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types. J. Virol. 76: 3452-3460 [Abstract] [Full Text]  
  • Mercier, S., Gahery-Segard, H., Monteil, M., Lengagne, R., Guillet, J.-G., Eloit, M., Denesvre, C. (2002). Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product. J. Virol. 76: 2899-2911 [Abstract] [Full Text]  
  • Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S.-S., Choppin, J., Gahery-Segard, H., Boulanger, P., Guillet, J.-G. (2002). Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response. J. Virol. 76: 127-135 [Abstract] [Full Text]  
  • Sen, L., Hong, Y.-S., Luo, H., Cui, G., Laks, H. (2001). Efficiency, efficacy, and adverse effects of adenovirus- vs. liposome-mediated gene therapy in cardiac allografts. Am. J. Physiol. Heart Circ. Physiol. 281: H1433-H1441 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»